Modelling the cost effectiveness of bronchodilators in COPD

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.471, 2005-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

COPD: economic impact of new bronchodilators

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 312, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Novel bronchodilators in the treatment of asthma and COPD

By Campillo Nuria Páez Juan Antonio

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 1, 2001-01 ,pp. : 53-63

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Budesonide/Formoterol in a Single Inhaler for COPD Compared with Each Monocomponent Used Alone

By Löfdahl Claes-Göran

PharmacoEconomics, Vol. 23, Iss. 4, 2005-01 ,pp. : 365-375

Adis International

Access to resources Recommend Favorite

Modelling the Cost Effectiveness of Treatments for Parkinson's Disease: A Methodological Review

By Dams Judith

PharmacoEconomics, Vol. 29, Iss. 12, 2011-12 ,pp. : 1025-1049

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analyses of Vaccination Programmes: A Focused Review of Modelling Approaches

By Kim Sun-Young Goldie Sue J.

PharmacoEconomics, Vol. 26, Iss. 3, 2008-01 ,pp. : 191-215

Adis International

Access to resources Recommend Favorite